Breaking News
April 23, 2018 - Key factor in development of Parkinson’s disease identified
April 23, 2018 - Higher consumption of fish linked to better neurological health
April 23, 2018 - Researchers clarify immune response for patients with breast cancer brain metastases
April 23, 2018 - Polypharmacy More Likely for Cancer Survivors
April 23, 2018 - Obesity is shifting cancer to young adults
April 23, 2018 - Scientists illustrate role of novel chromosomal mutations in fosfomycin resistance
April 23, 2018 - Newly developed drug compound may help treat Charcot-Marie-Tooth disease
April 23, 2018 - Marriage Means ‘I Do’ for Skin Cancer Detection
April 23, 2018 - Freezing hunger-signaling nerve may help ignite weight loss
April 23, 2018 - Wear exoskeletons with caution for heavy lifting, researchers say
April 23, 2018 - Research offers new hope for healing wounds in patients with diabetes
April 23, 2018 - Shorter courses of radiotherapy found to be safe, effective for prostate cancer patients
April 23, 2018 - Scientists use CRISPR tool to make multiple edits to DNA samples ‘in vitro’
April 23, 2018 - Knee reconstructions are on the rise among the youth in Australia
April 23, 2018 - Artificial sweeteners linked to obesity warn researchers
April 23, 2018 - CDC seeking $400 million to replace lab for deadliest germs
April 23, 2018 - Sensirion to present single-use liquid flow sensor at COMPAMED 2017
April 23, 2018 - FDA approves contact lenses that shade the sun
April 22, 2018 - Concussion recovery and symptom severity found to vary between men and women
April 22, 2018 - C. Difficile Risk Higher With Stoma Reversal Versus Colectomy
April 22, 2018 - Repeated ranibizumab doesn’t impair macular perfusion
April 22, 2018 - New microscope reveals how cells behave in 3D and real time inside living organisms
April 22, 2018 - Study shows clinical benefit and monetary gains of weight-loss surgery
April 22, 2018 - GNA Biosolutions launches world’s first Laser PCR platform at Medica Trade Fair
April 22, 2018 - Researchers present simulation model to investigate hospital responsiveness to mass casualty incidents
April 22, 2018 - Does Pot Really Dull a Teen’s Brain?
April 22, 2018 - Controversial pregnancy test drug shows deformities in zebrafish embryos within hours of exposure
April 22, 2018 - New research partnership makes childbirth safer in Mozambique
April 22, 2018 - Brief bedside visual art intervention reduces pain, anxiety in cancer patients
April 22, 2018 - The memory part of the brain may also hold clues for anxiety and depression
April 22, 2018 - AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients
April 22, 2018 - New Drug Combo Ups Survival in HER2/neu Uterine Serous Cancer
April 22, 2018 - Researchers chart a new way to look at concussion
April 22, 2018 - Every parent needs to know fundamental red flags for autism
April 22, 2018 - Anatotemp expands anatomic dental implant healing abutments with 4Side anti-rotational connection
April 22, 2018 - Gene Twist Can Make Your Blood Pressure Spike From Salt
April 22, 2018 - Study suggests failed osteoarthritis drug could help treat opioid addiction
April 22, 2018 - More Americans aware of growing problem of opioid addiction
April 22, 2018 - KHN’s ‘What the Health?’ Nothing in health care ever goes away
April 22, 2018 - BGS to promote high-quality sterilization services at Health GB in Manchester
April 22, 2018 - New integrated POC tool detects biomarkers of heart failure rapidly and precisely
April 22, 2018 - Direct electrical current can be delivered to nerves for blocking pain signals
April 22, 2018 - Newly Published Phase 2 Study Found Esketamine Demonstrated Significantly Rapid Improvements in Depressive Symptoms and Suicidality
April 22, 2018 - Healthy red blood cells owe their shape to muscle-like structures
April 22, 2018 - Researchers present case study of management of rheumatic mitral regurgitation in woman contemplating pregnancy
April 22, 2018 - New black Porvair Krystal UV Quartz microplates for Circular Dichroism measurements
April 22, 2018 - Advanced flow chemistry modules enhance control of nanoprecipitation
April 22, 2018 - Look! Down in the petri dish! It’s a superplatelet!
April 22, 2018 - Research reveals why people with tetraplegia more likely to suffer from sleep apnea
April 21, 2018 - New non-invasive nerve stimulation may offer relief for people with hand tremor
April 21, 2018 - Smartphone App May Up Medication Adherence in HTN
April 21, 2018 - Western diet depletes artery-protecting immune cells
April 21, 2018 - Excelitas Technologies launches new powerful LED light source for fluorescence microscopy
April 21, 2018 - Academia and high tech companies join forces to increase production capacity for microfluidic systems
April 21, 2018 - Developing cooking skills as young adult may have long-term health benefits
April 21, 2018 - Study compares survival outcomes of different drugs for type 2 diabetes
April 21, 2018 - More Than 40 Percent of Americans Breathe Dirty Air: Report
April 21, 2018 - Obstructive sleep apnea – Genetics Home Reference
April 21, 2018 - More evidence shows exposure to traffic and outdoor air pollution increases risk of asthma
April 21, 2018 - Novel gold nanoparticle technology could guide cancer treatment in real-time
April 21, 2018 - News coverage of Ebola impacted public’s perception on disease and survivors
April 21, 2018 - S.Africa’s DIY battle against HIV
April 21, 2018 - Children with autism have gastrointestinal and immune system deregulation, research finds
April 21, 2018 - Human brain processes sight and sound in the same way, shows study
April 21, 2018 - Evolutionary history of tumor helps predict severity of prostate cancer
April 21, 2018 - Pepper plant metabolizes antibiotic in personal care products
April 21, 2018 - Tradeshow Talks with Integra
April 21, 2018 - EPFL becomes part of Chan Zuckerberg’s project to develop Human Cell Atlas
April 21, 2018 - Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy
April 21, 2018 - Breaking through the HIV vaccine ‘logjam’
April 21, 2018 - IntelliCyt introduces new QSol buffer to enable robust, consistent sampling
April 21, 2018 - Scientists publish comprehensive lineage tree of whole adult animal in Science journal
April 21, 2018 - Innovative method based on FluidFM technology could revolutionize biological research
April 21, 2018 - Americans world’s biggest TV addicts, watching four hours a day
April 21, 2018 - Investigational drug may help increase protein levels in babies with spinal muscular atrophy
April 21, 2018 - Study shows distinctions between age groups in predicting and responding to stress at home
April 21, 2018 - Aziyo Biologics, BIOTRONIK enter into US co-distribution agreement
April 21, 2018 - Opiate Use Linked to Early Mortality in IBD Patients
April 21, 2018 - Online ads help pregnant smokers quit
April 21, 2018 - Opioid pain medications may not be safe for hemodialysis patients
Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration

Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration

image_pdfDownload PDFimage_print

Once funding is obtained, researchers can perform a clinical trial to test the efficacy of transplanting bone marrow cells into muscles to stop deterioration caused by the illness. The method has already yielded positive results on mice.

The Neuroscience Institute at the Universidad Miguel Hernández (UMH) in Elche, Alicante, and the Spanish National Research Council (CSIC) are actively searching for €492,800 to be able to develop a worldwide pioneering test on 100 patients suffering from amyotrophic lateral sclerosis (ALS) which could, by using adult stem cells, stop the progressive deterioration of the locomotor apparatus – which eventually leads to patients’ death. This therapy is spearheaded by the director of the Neuroscience Institute, Salvador Martínez, and has been successfully tested on mice.

The clinical trial would be undertaken over a three year period in the Virgen de la Arrixaca (Murcia), Hospital General (Alicante) and Sant Joan d’Alacant (Alicante) hospitals in eastern Spain and, if successful, would make it possible to then treat, for example, the 900 patients that are diagnosed with ALS every year in Spain, stopping the progressive and inevitable paralysis of their muscles. Neuroscience Institute manager Salvador Martínez has been looking into therapies to fight ALS for two decades, and as the head of a group of a dozen scientists, has been able to verify in a laboratory that transplanting bone marrow cells to the muscles stops the deadly progressive muscular deterioration caused by this illness.

This is possible because adult stem cells from the bone marrow act as guards and prevent the death of motor neurons (named as such because they are in charge of muscle movement), with the added benefit that there is no cell rejection because the transplanted cells are from the same patient. However, a lack of public resources has so far kept testing on humans from being a possibility due to the associated costs. Therefore, the hospitals from Murcia and Alicante have requested a financing project to the Carlos III Health Institute in Madrid, the national entity which covers clinical trials with no commercial purpose.

The objective is to test the transplant of bone marrow cells in the tibialis anterior muscle (located near the shin and which dorsiflexes, or lifts, the foot) as well as in the hand muscles, where the loss of strength due to the illness if clinically very noticeable. The trial would be double-blind and would consist of inoculating the muscles of one hand with bone marrow cells and those in the other with a placebo, without the doctor or the patient knowing which is which.

Once the financing is covered, the study will have to be verified by Spanish Medicine Agency AEMPS before it can be worked on as a potential therapeutic option, which would then make it possible to test other muscles commonly affected by the disease, such as the diaphragm. Martínez explains that ‘this method of transplant keeps our hopes of being much more effective alive, because we can introduce many cells into a muscle, as many as we need, and the amount of times necessary (depending on the size of the muscle). Furthermore, the transplant is performed without surgery and only requires local anaesthetic.’

He explains that public funds are needed to proceed with this line of research against ALS, as this type of therapy ‘isn’t interesting for pharmaceutical laboratories’ because it uses ‘the patient’s own cells’ instead of marketable products.

As many as 100 patients from anywhere in the country would take part in the trial, as long as they have the green light to be recruited by their neurologist. Once the initial transplant is performed in the Arrixaca hospital, electromyography tests would be performed every three months for at least a year in the Hospital General and the Hospital de Sant Joan d’Alacant in order to objectively measure the evolution of the muscle’s strength and range of movement.

Groups from Italy and Norway have already shown interest in this therapy and have asked the Neuroscience Institute for information in order to perform similar tests in their countries. Basic research has been performed in the Institute, located in the Sant Joan d’Alacant campus of the UMH, and has been financed for years by programs of the Spanish Government, the EU and the Spanish Network for Cellular Treatment (TerCel), as well as donations from trusts such as Diógenes and Rotary Illice.

On average, more than two people are diagnosed with ALS every day in Spain, an illness with no cure which only has low-efficiency palliative care treatment available, as it only prolongs a patient’s life by about six months within a three to five year life expectancy period. A genetic origin has been established for 10% of cases, but it remains unknown for the rest, leading to the appearance of theories related to genetic and environmental predisposing factors.

Source:

Stem cell transplants could stop ALS muscle deterioration

Tagged with:

About author

Related Articles